Skip to main content
. 2024 Sep 19;19(9):e0310531. doi: 10.1371/journal.pone.0310531

Table 1. Characteristics of early-stage (AJCC I-III) breast cancer (BC) patients diagnosed with dyslipidemia and prescribed a statin (dyslipidemia cohort), Pathways Heart Study.

  Dyslipidemia Cohort
  (n = 4,776)
  mean sd
Length of KPNC membership (months) 205 57
COPS2 comorbidity score at BC diagnosis 18 19
BMI (kg/m 2 ) at BC diagnosis 30 6
Age (years) at BC diagnosis 67 10
Median neighborhood household income ($) 78,644 34,071
  n %
Race/ethnicity
    White 3,104 64.99
    Black 379 7.94
    Asian 681 14.26
    Hispanic 556 11.64
    Pacific Islander 24 0.50
    American Indian / Alaskan Native 32 0.67
Smoking status at BC diagnosis
    Never smoker 2,398 50.21
    Quit/former smoker 1,492 31.24
    Current smoker 463 9.69
    Unknown 423 8.86
Menopausal Status at BC diagnosis
    Post-menopausal 4,512 94.47
    Pre-menopausal 264 5.53
AJCC Stage
    I 2,835 59.36
    II 1,515 31.72
    III 426 8.92
Received Chemotherapy 1,747 36.58
Received Radiation Therapy 3,038 63.61
Received Endocrine Therapy 3,551 74.35
History of dyslipidemia before BC -- --
History of hypertension before BC 3,450 72.24
History of diabetes before BC 1,615 33.81
History of ischemic heart disease before BC 277 5.80
History of heart failure before BC 127 2.66
History of stroke before BC 56 1.17
History of any CVD before BC 420 8.79